iForumRx.org

iForumRx.org

By American College of Clinical PharmacyMedicineHealth & Fitness
Download on the App Store

iForumRx.org episodes

  • Complex Patient Case 2 - Managing Adverse Effects

    Reason for Visit: The patient is here today for hypotension and diabetes follow-up. The primary care physician has consulted the clinical pharmacist regarding hypotension.

    Chief Complaint: “I feel dizzy when I stand up and feel like my heart is racing. I have never passed out, but it feels like I might, and I usually have to sit back down."

    Guest Authors:  Kellie Ball, PharmD and Johnathon Proctor, PharmD

    Expert Panelists:  Morgan Weaver Godfrey, PharmD, BCPS and Richard J. Silvia, PharmD, BCPP

    27 min
  • Preventing Autoimmune Disease: Can Supplements Get the Job Done?

    Currently, there are no known safe, effective, and inexpensive ways that can prevent or reduce the risk of developing autoimmune diseases. Any strategy that could reduce the chances of developing an autoimmune disorder would be welcomed by practitioners and patients alike.  Perhaps vitamin D and omega 3 fatty acid supplementation can get the job done.

    Guest Authors: Rileigh Provenza, PharmD and Nicole Slater, PharmD, BCACP

    Music by Good Talk

    20 min
  • Top Ten Things Every Clinician Should Know About Treating Obesity

    Obesity is a chronic, progressive, multi-factorial, neurobehavioral disease characterized by excessive adipose tissue.  Here are some things every clinician should know about treating overweight and obesity but be sure to read the written commentary posted on iForumRx.org

    Guest Authors:  Jennifer N. Clements, PharmD, BCPS, BCACP, CDCES, BC-ADM and Seena L. Haines, PharmD., BCACP, NBC-HWC, CHWC

    Music by Good Talk

    26 min
  • Managing RAAS-Inhibitor-Associated Hyperkalemia in Patients with CKD – A Balancing Act

    Hyperkalemia is a common electrolyte disorder in patients with CKD that can be exacerbated by renin-angiotensin-aldosterone system (RAAS) inhibitors. While hyperkalemia poses potential risks to patients with CKD, the potentially negative impact of discontinuing RAAS inhibitor therapy on long-term renal and cardiovascular outcomes in CKD patients is unclear.

    Guest Author: Michelle A. Fravel, PharmD, BCPS

    Music by Good Talk

    24 min
  • Complex Patient Case - Women’s Health + Contraception

    Reason for Visit: JS was referred by her PCP to the ambulatory care pharmacist for contraceptive counseling.

    Chief Complaint: “I think I’m leaning more towards the pill, but I’m really open to anything. It’s also itchy again down there, probably another yeast infection.”

    Guest Author:  Elizabeth Salisbury, PharmD

    Expert Panelists:  Ashley Meredith, PharmD, MPH, BCACP; Rebecca Stone, PharmD, BCACP, and Sally Rafie, PharmD, BCPS

     

    Wanna earn continuing pharmacy education (CPE) for this program?  Be sure to log-in to the iForumRx website, review the case, listen to the podcast, and scroll to the bottom of the page to claim CE.

     

    Check out the Birth Control Pharmacist website.

    --------

    31 min
  • Top Ten Podcasts Every Ambulatory Care Clinician Should Know About

    What is the secret to staying up to date with clinical updates, tips for flourishing in your practice and life, and inspirational stories about pharmacist entrepreneurs…all at the click of a button? No, it is not magic. It is a podcast!

    Guest Authors: Elizabeth Yett, PharmD, BCACP, TTS and Elizabeth Hearn, PharmD, BCACP

    Music by Good Talk

    16 min
  • The Generic Levothyroxine Conundrum

    Would you be willing to pay three times more for a brand-name levothyroxine product than a generic equivalent? Clinical practice guidelines recommend against switching between products. As a result, levothyroxine has higher brand-name product dispensing rates than other medications, costing patients and the healthcare system much more money.

    Guest Authors:  Connie Liang, PharmD and Kathleen Pincus, PharmD, BCPS, BCACP

    Music by Good Talk

    23 min
  • Is Icosapent Ethyl a QALY-ty Investment?

    The landmark REDUCE-IT trial demonstrated that icosapent ethyl (IPE) 4 g daily significantly reduced cardiovascular events in high-risk patients when added to statin therapy, but is a fancy fish oil supplement really worth our coin?

    Guest Authors:  Joseph Nardolillo, PharmD, BCACP and Vivian Cheng, PharmD, BCPS, BCACP

    Music by Good Talk

    25 min
  • Level Up! An Abstinence Game for Smoking Cessation

    Smoking remains a habit for many people, even among those who are motivated to quit. Historically, most smoking cessation interventions have targeted individuals who are ready to quit smoking in the next 30 days, overlooking those who are not yet ready to quit.  Perhaps an abstinence game, Take a Break, can move people in pre-contemplation and contemplation toward quitting.

    Guest Authors:  Anna Rhett, PharmD and Ha K. Pham, PharmD, BCACP

    Music by Good Talk

    16 min

About iForumRx.org

From the publisher's feed

We explore the evidence that informs ambulatory care pharmacy practice. Check out our website & podcasts, & consider submitting a commentary!